Stocktoria
ProMIS Neurosciences Inc. PMN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2017-04-03
ProMIS Neurosciences Inc. statistics & valuation
Market cap$22.7M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -432.6% | 14.7% | -97.0% | -260.8% | -55.2% |
| Return on equity | 3155.8% | 16.9% | -352.0% | 1340.2% | -173.0% |
| Debt / equity | — | — | 0.00× | — | 0.69× |
| Current ratio | 0.88 | 8.52 | 1.46 | 1.08 | 19.07 |
Source: SEC EDGAR filings · CIK 0001374339 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.